Incyte to Present at Upcoming Investor Conference

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

conferences

04/27/2021 - 08:00 AM

Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities Virtual 2021 Healthcare Conference on Thursday, May 13, 2021 at 12:30 p.m. ET.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 90 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210427005031/en/

Incyte Corp

NASDAQ:INCY

INCY Rankings

#720 Ranked by Market Cap

N/A Ranked by Dividends

INCY Latest News

Jun 20, 2025

Update on FDA Review of Ruxolitinib Cream (Opzelura®) for Children Ages 2-11 with Atopic Dermatitis

Jun 18, 2025

Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Jun 15, 2025

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

Jun 15, 2025

Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025

Jun 12, 2025

Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

INCY Stock Data

Market Cap 13.40B

Float 188.94M

Insiders Ownership 1.99%

Institutions Ownership 96.76%

Short Percent 3.02%

Industry Biotechnology

Sector Services-commercial Physical & Biological Research

Website Link

Country United States

City WILMINGTON